Albemarle
Stock Forecast, Prediction & Price Target
Albemarle (ALB) stock Price Target by analysts
Albemarle (ALB) stock Price Target by analysts
Average Price Target
$116.33
Potential upside: 44.51%
Albemarle price prediction
What is Albemarle stock analysts` prediction?
Albemarle stock forecast: Based on 3 Wall Street analysts` predicted price targets for Albemarle in the last 3 months, the avarage price target is $116.33, with a high forecast of $NaN. The average price target represents a 44.51% change from the last price of $80.5.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Albemarle stock Price Target by analysts
Full breakdown of analysts given Albemarle price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Andres Castanos-Mollor Berenberg Bank | 0% 0/3 | 10 months ago | $102 26.70% upside | $81.65 | StreetInsider | Previous targets (2) |
Aleksey Yefremov KeyBanc | 0% 0/3 | 10 months ago | $127 57.76% upside | $98.57 | StreetInsider | Previous targets (2) |
Laurence Alexander Jefferies | 50% 1/2 | 11 months ago | $120 49.06% upside | $96.05 | StreetInsider | Previous targets (1) |
Joel Jackson BMO Capital | 0% 0/1 | about 1 year ago | $150 86.33% upside | $77.81 | StreetInsider | Previous targets (0) |
Charles Neivert Piper Sandler | 0% 0/4 | about 1 year ago | $90 11.80% upside | $80.4 | StreetInsider | Previous targets (3) |
Arun Viswanathan RBC Capital | 0% 0/2 | about 1 year ago | $111 37.88% upside | $81.05 | StreetInsider | Previous targets (1) |
Aleksey Yefremov KeyBanc | 0% 0/3 | about 1 year ago | $132 63.97% upside | $83.8 | StreetInsider | Previous targets (2) |
Andres Castanos-Mollor Berenberg Bank | 0% 0/3 | about 1 year ago | $83 3.10% upside | $92.51 | StreetInsider | Previous targets (2) |
Charles Neivert Piper Sandler | 0% 0/4 | about 1 year ago | $95 18.01% upside | $92.77 | StreetInsider | Previous targets (3) |
Joshua Spector UBS | 0% 0/1 | about 1 year ago | $124 54.03% upside | $112.65 | TheFly | Previous targets (0) |
Bill Selesky Argus Research | 50% 1/2 | about 1 year ago | $166 106.21% upside | $112.65 | StreetInsider | Previous targets (1) |
Charles Neivert Piper Sandler | 0% 0/4 | over 1 year ago | $122 51.55% upside | $124.38 | StreetInsider | Previous targets (3) |
Ben Isaacson Scotiabank | 0% 0/2 | over 1 year ago | $135 67.70% upside | $127.5 | TheFly | Previous targets (1) |
Corinne Blanchard Deutsche Bank | 0% 0/1 | over 1 year ago | $140 73.91% upside | $130.78 | StreetInsider | Previous targets (0) |
Ben Isaacson Scotiabank | 0% 0/2 | over 1 year ago | $150 86.33% upside | $129.65 | TheFly | Previous targets (1) |
Arun Viswanathan RBC Capital | 0% 0/2 | over 1 year ago | $157 95.03% upside | $128.1 | StreetInsider | Previous targets (1) |
Andres Castanos-Mollor Berenberg Bank | 0% 0/3 | over 1 year ago | $160 98.75% upside | $127.65 | StreetInsider | Previous targets (2) |
Chris Kapsch Loop Capital Markets | 50% 1/2 | over 1 year ago | $162 101.24% upside | $131.17 | TheFly | Previous targets (1) |
Colin Rusch Oppenheimer | 50% 1/2 | almost 2 years ago | $308 282.60% upside | $122.67 | Benzinga | Previous targets (1) |
Joel Jackson Loop Capital Markets | 0% 0/1 | almost 2 years ago | $180 123.60% upside | $122.67 | Benzinga | Previous targets (0) |
Charles Neivert Piper Sandler | 0% 0/4 | almost 2 years ago | $155 92.54% upside | $135.32 | Benzinga | Previous targets (3) |
Ben Kallo Robert W. Baird | 0% 0/1 | over 2 years ago | $288 257.76% upside | $203.99 | Benzinga | Previous targets (0) |
Aleksey Yefremov KeyBanc | 0% 0/3 | over 2 years ago | $270 235.40% upside | $194.51 | StreetInsider | Previous targets (2) |
Unknown UBS | N/A | over 2 years ago | $250 210.55% upside | $235.62 | Benzinga | N/A |
Unknown Citigroup | N/A | over 2 years ago | $295 266.45% upside | $247.86 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | almost 3 years ago | $155 92.54% upside | $264.64 | Benzinga | N/A |
Jonathan Petersen Jefferies | 100% 1/1 | about 3 years ago | $320 297.51% upside | $212.04 | Pulse 2.0 | Previous targets (0) |
Edward Kelly Wells Fargo | 100% 1/1 | over 3 years ago | $215 167.08% upside | $190.37 | StreetInsider | Previous targets (0) |
PJ Juvekar Citigroup | 100% 1/1 | over 3 years ago | $244 203.10% upside | $190.37 | TheFly | Previous targets (0) |
John Roberts UBS | 100% 1/1 | over 3 years ago | $320 297.51% upside | $190.76 | Pulse 2.0 | Previous targets (0) |
Chris Parkinson Mizuho Securities | 100% 1/1 | over 3 years ago | $243 201.86% upside | $196.61 | TheFly | Previous targets (0) |
Colin Rusch Oppenheimer | 50% 1/2 | over 3 years ago | $307 281.36% upside | $196.61 | TipRanks Contributor | Previous targets (1) |
Santhosh Seshadri HSBC | 100% 1/1 | over 3 years ago | $280 247.82% upside | $205.2 | TheFly | Previous targets (0) |
David Deckelbaum Cowen & Co. | 100% 1/1 | over 3 years ago | $275 241.61% upside | $232.62 | TipRanks | Previous targets (0) |
Robert Koort Goldman Sachs | 100% 1/1 | over 3 years ago | $205 154.65% upside | $238.9 | Barrons | Previous targets (0) |
Chris Kapsch Loop Capital Markets | 50% 1/2 | almost 4 years ago | $280 247.82% upside | $214.42 | TheFly | Previous targets (1) |
Laurence Alexander Jefferies | 50% 1/2 | almost 4 years ago | $300 272.67% upside | $218.16 | Investing | Previous targets (1) |
Bill Selesky Argus Research | 50% 1/2 | about 4 years ago | $278 245.34% upside | $237.75 | TipRanks | Previous targets (1) |
Vincent Andrews Morgan Stanley | 100% 1/1 | over 4 years ago | $80 -0.62% downside | $158.27 | TipRanks | Previous targets (0) |
Albemarle Financial Estimates
Albemarle Revenue Estimates
Albemarle EBITDA Estimates
Albemarle Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $3.32B N/A | $7.32B 119.95% | $9.61B 31.38% | Avg: $7.07B Low: $6.14B High: $8.69B avg. -26.42% | Avg: $8.32B Low: $7.26B High: $10.63B avg. 17.66% | Avg: $9.15B Low: $7.98B High: $11.68B avg. 9.91% | Avg: $10.27B Low: $8.96B High: $13.11B avg. 12.23% |
Net Income
% change YoY
| $123.67M N/A | $2.04B 1551.83% | $1.57B -22.97% | Avg: $1.25B Low: $443.97M High: $3.24B avg. -20.06% | Avg: $2.82B Low: $763.12M High: $2.39B avg. 124.30% | Avg: $1.54B Low: $1.28B High: $2.10B avg. -45.21% | Avg: $2.14B Low: $1.78B High: $2.91B avg. 38.49% |
EBITDA
% change YoY
| $153.12M N/A | $2.86B 1771.47% | $792.75M -72.33% | Avg: $1.35B Low: $1.17B High: $1.66B avg. 70.75% | Avg: $1.59B Low: $1.39B High: $2.03B avg. 17.66% | Avg: $1.75B Low: $1.52B High: $2.23B avg. 9.91% | Avg: $1.96B Low: $1.71B High: $2.50B avg. 12.23% |
EPS
% change YoY
| $1.07 N/A | $17.44 1529.90% | $13.41 -23.10% | Avg: $10.32 Low: $3.77 High: $27.53 avg. -23.03% | Avg: $11.37 Low: $6.48 High: $20.3 avg. 10.19% | Avg: $13.12 Low: $10.95 High: $17.85 avg. 15.38% | Avg: $18.18 Low: $15.17 High: $24.72 avg. 38.49% |
Operating Expenses
% change YoY
| $495.50M N/A | $596.12M 20.30% | $945.02M 58.52% | Avg: $822.37M Low: $714.68M High: $1.01B avg. -12.97% | Avg: $967.63M Low: $844.51M High: $1.23B avg. 17.66% | Avg: $1.06B Low: $928.23M High: $1.35B avg. 9.91% | Avg: $1.19B Low: $1.04B High: $1.52B avg. 12.23% |
FAQ
What is Albemarle stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 24.37% in 2025-2028.
We have gathered data from 14 analysts. Their low estimate is 443.97M, average is 1.25B and high is 3.24B.
What is Albemarle stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 3.34% in 2025-2028.
We have gathered data from 18 analysts. Their low revenue estimate is $6.14B, average is $7.07B and high is $8.69B.
What is Albemarle stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 10.26% in 2025-2028.
We have gathered data from 14 analysts. Their low earnings per share estimate is $3.77, average is $10.32 and high is $27.53.
What is the best performing analyst?
In the last twelve months 3 analysts have been covering Albemarle stock. The most successful analyst is Andres Castanos-Mollor.